Omega Fund Management, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001637359 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 2, 2016

Total Value: $131M (100.0% shares, 0.0% debt)

Holdings (11)

— Juno Therapeutics 28.2%

Value $36.9M Shares 1,229,512 Est. Cost $52.22 Unrealized —

— Paratek Pharmaceuticals 25.8%

Value $33.83M Shares 2,600,410 Est. Cost $34.18 Unrealized —

— Egalet 16.8%

Value $21.99M Shares 2,889,926 Est. Cost $5.98 Unrealized —

— FibroGen 13.0%

Value $17.02M Shares 822,175 Est. Cost $27.34 Unrealized —

— Nabriva Therapeutics 6.2%

Value $8.079M Shares 1,145,890 Est. Cost $9.50 Unrealized —

— ESSA Pharma 3.6%

Value $4.667M Shares 1,696,969 Est. Cost $5.22 Unrealized —

— Pieris Pharmaceuticals 2.6%

Value $3.384M Shares 1,848,984 Est. Cost $1.83 Unrealized —

— Proteon Therapeutics 1.8%

Value $2.333M Shares 250,000 Est. Cost $10.40 Unrealized —

— Dicerna Pharmaceuticals 1.0%

Value $1.314M Shares 223,457 Est. Cost $16.47 Unrealized —

EDIT Editas Medicine 0.7%

Value $892K Shares 66,162 Est. Cost $26.29 Unrealized -22.1%

— CymaBay Therapeutics 0.4%

Value $585K Shares 301,477 Est. Cost $1.94 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Juno Therapeutics	1,229,512	$36.9M	28.2%	$52.22	—	Common Stock	48205A109
—	Paratek Pharmaceuticals	2,600,410	$33.83M	25.8%	$34.18	—	Common Stock	699374302
—	Egalet	2,889,926	$21.99M	16.8%	$5.98	—	Common Stock	28226B104
—	FibroGen	822,175	$17.02M	13.0%	$27.34	—	Common Stock	31572Q808
—	Nabriva Therapeutics	1,145,890	$8.079M	6.2%	$9.50	—	Sponsored ADR	62957M104
—	ESSA Pharma	1,696,969	$4.667M	3.6%	$5.22	—	Common Stock	29668H104
—	Pieris Pharmaceuticals	1,848,984	$3.384M	2.6%	$1.83	—	Common Stock	720795103
—	Proteon Therapeutics	250,000	$2.333M	1.8%	$10.40	—	Common Stock	74371L109
—	Dicerna Pharmaceuticals	223,457	$1.314M	1.0%	$16.47	—	Common Stock	253031108
EDIT	Editas Medicine	66,162	$892K	0.7%	$26.29	-22.1%	Common Stock	28106W103
—	CymaBay Therapeutics	301,477	$585K	0.4%	$1.94	—	Common Stock	23257D103